Your browser doesn't support javascript.
loading
Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study.
Tan, Alice J; Xia, Joyce; Glennon, Colleen M; Locascio, Joseph J; Gabel, Colleen K; Nguyen, Emily D; Chand, Sidharth; Rrapi, Renajd; Dobry, Allison S; Garza-Mayers, Anna Cristina; Ko, Lauren N; Shah, Radhika; St John, Jessica; Nigwekar, Sagar U; Kroshinsky, Daniela.
Afiliação
  • Tan AJ; Department of Dermatology, Massachusetts General Hospital.
  • Xia J; Department of Dermatology, Massachusetts General Hospital.
  • Glennon CM; Department of Dermatology, Massachusetts General Hospital.
  • Locascio JJ; Harvard Catalyst Biostatistics, Massachusetts General Hospital.
  • Gabel CK; Department of Dermatology, University of Massachusetts Medical School.
  • Nguyen ED; Department of Dermatology, University of Colorado School of Medicine.
  • Chand S; Department of Dermatology, Massachusetts General Hospital.
  • Rrapi R; Department of Dermatology, Massachusetts General Hospital.
  • Dobry AS; Department of Dermatology, University of California, San Francisco School of Medicine.
  • Garza-Mayers AC; Department of Dermatology, Massachusetts General Hospital.
  • Ko LN; Department of Dermatology, Brigham and Women's Hospital.
  • Shah R; Department of Dermatology, Robert Wood Johnson Medical School.
  • St John J; Department of Dermatology, University of Massachusetts Medical School.
  • Nigwekar SU; Department of Nephrology, Massachusetts General Hospital.
  • Kroshinsky D; Department of Dermatology, Massachusetts General Hospital. Electronic address: dkroshinsky@mgh.harvard.edu.
J Am Acad Dermatol ; 2024 Jul 05.
Article em En | MEDLINE | ID: mdl-38972479
ABSTRACT

BACKGROUND:

Calciphylaxis patients historically have experienced diagnostic challenges and high morbidity, however limited data is available examining these characteristics over time.

OBJECTIVE:

The primary goals were to a) investigate factors associated with diagnostic delay of calciphylaxis and b) assess morbidity outcomes. The secondary goal was to provide updated mortality rates.

METHODS:

A retrospective review of 302 adult patients diagnosed with calciphylaxis between January 1, 2006 and December 31, 2022 was conducted. Univariate and multivariate statistical analyses were performed.

RESULTS:

Non-nephrogenic calciphylaxis (p=0.0004) and involvement of the fingers (p=0.0001) were significantly associated with an increased diagnostic delay, whereas involvement of the arms (p=0.01) and genitalia (p=0.022) resulted in fewer days to diagnosis. Almost all patients with genitalia, finger, or toe involvement had nephrogenic disease. The number of complications per patient decreased with time, especially for wound infections (p=0.028), increase in lesion number (p=0.012), and recurrent hospitalizations (p=0.020). Updated 1-year mortality rates were 36.70% and 30.77% for nephrogenic and non-nephrogenic calciphylaxis, respectively.

LIMITATIONS:

Limitations include the retrospective nature and data from a single institution.

CONCLUSION:

Diagnostic delay, particularly in non-nephrogenic calciphylaxis, and complications per patient decreased with time, highlighting the importance of continued awareness to expedite diagnosis. Mortality rates have continued to improve in recent years.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2024 Tipo de documento: Article